The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
WIT Legal ("WIT"), the leading agency representing testifying experts for high-stakes, complex legal matters, today released their annual report evaluating Hatch-Waxman litigation. The report, 2024 in ...
Padagis®, a leading generic manufacturer, announced today it is lowering the price of its over-the-counter (OTC) 4 mg ...
The vending machine dispenses naloxone, a medicine that rapidly reverses an opioid overdose, and fentanyl test strips. SCHD said the items will be provided at no cost and with no questions asked.
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...
On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray, Spravato (esketamine), to treat major depressive disorder. Oral antidepressants are the most common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback